| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.1 |